Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Cash & Equivalents (2016 - 2025)

Merit Medical Systems' Cash & Equivalents history spans 16 years, with the latest figure at $446.4 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 18.5% year-over-year to $446.4 million; the TTM value through Dec 2025 reached $446.4 million, up 18.5%, while the annual FY2025 figure was $446.4 million, 18.5% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $446.4 million at Merit Medical Systems, up from $392.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $636.7 million in Q2 2024 and bottomed at $51.5 million in Q3 2022.
  • The 5-year median for Cash & Equivalents is $70.9 million (2021), against an average of $248.1 million.
  • The largest annual shift saw Cash & Equivalents soared 905.06% in 2023 before it plummeted 46.31% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $67.8 million in 2021, then decreased by 13.79% to $58.4 million in 2022, then skyrocketed by 905.06% to $587.0 million in 2023, then tumbled by 35.83% to $376.7 million in 2024, then increased by 18.5% to $446.4 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Cash & Equivalents are $446.4 million (Q4 2025), $392.5 million (Q3 2025), and $341.8 million (Q2 2025).